Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP32P4 is a human pseudogene named "Ubiquitin specific peptidase 32 pseudogene 4," derived from the protein-coding gene for ubiquitin specific peptidase 32 (USP32). Pseudogenes are segments of DNA similar to known genes but typically lack the ability to produce a functional protein due to mutations, deletions, or truncations; therefore, most are not considered direct therapeutic targets[1][2][3]. While some pseudogenes may have roles in regulating gene expression via noncoding RNA mechanisms, the specific biological function and therapeutic implications for USP32P4 have not been described in referenced databases[1][2][3]. It is primarily classified as a genomic element with no confirmed protein product or drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 32 pseudogene 4 (USP32P4).